Company Filing History:
Years Active: 2019
Title: Lucien McBeth: Innovator in Cancer Research
Introduction
Lucien McBeth is a notable inventor based in Toledo, Ohio. He has made significant contributions to the field of cancer research through his innovative work. His research focuses on targeting the human glucocorticoid receptor beta, which has implications for cancer treatment.
Latest Patents
Lucien McBeth holds a patent for a peptide nucleic acid (PNA) known as Sweet-P. This patent describes compositions and methods for making and using this PNA in targeting the glucocorticoid receptor beta in cancer. His work represents a promising advancement in therapeutic strategies for cancer patients.
Career Highlights
Lucien McBeth is affiliated with the University of Toledo, where he conducts his research. His academic background and ongoing research efforts contribute to the advancement of medical science, particularly in oncology.
Collaborations
Lucien collaborates with Terry D Hinds, Jr., who is also involved in research related to cancer. Their partnership enhances the potential for innovative solutions in the field.
Conclusion
Lucien McBeth's work exemplifies the intersection of innovation and medical research, particularly in cancer treatment. His contributions are paving the way for future advancements in this critical area of healthcare.